Retatrutide

Retatrutide is an investigational multi-receptor agonist designed to activate three metabolically relevant signaling pathways: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors.

Through its activity across these three receptor systems, Retatrutide is studied in research involving appetite and energy-intake regulation, glucose metabolism, lipid metabolism, energy expenditure, and body-weight-related metabolic mechanisms. Its multi-target profile has made it an important research compound in metabolic biology, obesity, and related metabolic research.

Retatrutide remains an investigational compound, and its safety and efficacy continue to be evaluated through clinical research.

For laboratory and research use only. Not for human consumption.

Livraison standard offerte dès 50 $ vers les États-Unis, le Canada, le Mexique et l'Europe. Expédition sous 1 jour ouvré.

Pas convaincu ? Renvoyez le produit sous 30 jours pour un remboursement intégral, même ouvert.